Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
IT heads into its November 3 results with an unusual combination: short interest running near a one-month high, options positioning that has just turned notably less defensive, and analysts nudging targets higher without committing to a bull case.
Short interest at 11.1% of the free float is the headline positioning fact this week. That figure is up about 12% over the past month, a meaningful build, though it has pulled back slightly over the past week as the position plateaued near 8 million shares. The ORTEX short score has held in a tight range around 56 for the past two weeks, consistent with a moderately elevated but stable short book. The good news for bears is that borrow conditions remain trivially easy: cost to borrow is just 0.47%, and availability is at roughly 18 times the current short interest, meaning there is no squeeze pressure in the lending market at all. The 52-week low availability reading was 291%, still extraordinarily loose by any standard, so shorts face no mechanical pressure to cover.
Options tell a different story from the shorts. The put/call ratio has dropped to 0.78, notably below its 20-day average of 0.92, and options positioning was far more defensive through most of September, when the PCR ran above 1.18 for an extended stretch. That hedging wave has now unwound almost entirely. The shift may reflect positioning clean-up after the stock's August 4 earnings jump, when IT rose 23% in a single session and held most of that gain through the following week. Investors who bought downside protection into that print are no longer renewing it.
The Street is broadly neutral but modestly more constructive at the margin. This week Morgan Stanley's Toni Kaplan raised her target to $182 from $177 while keeping an Equal-Weight rating, and UBS lifted its target to $208 from $196 last Monday, also holding at Neutral. Those two moves leave the mean target at $186, barely above the current price of $185.77, which tells you the consensus view: fairly priced, not a screaming buy. Wells Fargo holds the bearish flag with an Underweight and a $150 target, citing pressure on contract value growth and risk from AI substitutes undercutting Gartner's pricing power. The bull case rests on recurring subscription revenue, a large addressable market in enterprise advisory, and a management team with a track record of shareholder-friendly capital returns. Valuation multiples have crept up over the past month: the P/E is at 11.7x and the EV/EBITDA at 8.2x, both drifting slightly higher, though neither looks extreme relative to the company's historical range.
Institutional ownership is notable for its concentration among active managers. Baron Capital holds 12% of shares outstanding and added roughly 1.7 million shares in the quarter to June, while Independent Franchise Partners holds 8.8% and added close to 1 million shares in the same period. AQR has also been building, adding 636,000 shares to reach 6.6% of shares. Against that, the Vanguard Group's main entity filed a 13G/A in March showing a reduction from 12.4% to zero, though Vanguard Capital Management and Vanguard Portfolio Management filed fresh 13G disclosures in April showing combined stakes of around 12.6%. As the disclosure note cautions, these are event-driven filings around the 5% threshold and positions may have shifted since. Insider activity in recent weeks has been dominated by small transaction-code J entries for directors, which are typically non-cash compensation settlements rather than open-market purchases, and the net insider position over 90 days is modestly negative, around $1.4 million sold.
Retail attention is running above its recent baseline. ORTEX's Wikipedia-based signal shows a z-score of 1.78 against the prior 90-day history, the highest attention reading in the data window, as of September 22. That likely reflects the August earnings reaction, which generated significant press coverage, but the signal has not faded as quickly as might be expected.
With earnings 26 days away and the options market now leaning bullish relative to its recent posture, the question for the next few weeks is whether the short book at 11% of float begins to unwind ahead of the print, given how dramatically the last release moved the stock, or whether bears press the position further in anticipation of a tougher macro backdrop weighing on enterprise IT spending decisions.
See the live data behind this article on ORTEX.
Open IT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
